Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Merck & Co. 16.286, AstraZeneca 15.288.
Merck & Co. vs AstraZeneca Net Worth and Market Cap
Merck & Co. (MRK) and AstraZeneca (AZN) are peers in GLP-1. Merck & Co. reported revenue of $16.3B as of Q1 2026, compared with $15.3B for AstraZeneca. Merck & Co. leads on revenue.
Merck & Co.'s gross margin is 81.9% versus 82.5% for AstraZeneca. Merck & Co.'s net margin is -26.0% versus 20.1% for AstraZeneca.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Merck & Co., AstraZeneca.| Metric | Merck & Co. | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $16.29B | $15.29B |
| Cost of Revenue | $2.94B | $2.68B |
| Gross Profit | $13.34B | $12.61B |
| Operating Income | $-1.88B | $4.25B |
| Net Income | $-4.24B | $3.08B |
| R&D Expense | $12.56B | $3.49B |
| Earnings Per Share | -$1.72 | $1.97 |
| Gross Margin | 81.9% | 82.5% |
| Operating Margin | -11.6% | 27.8% |
| Net Profit Margin | -26.0% | 20.1% |
| Free Cash Flow | $2.93B | $1.82B |
| Cumulative Free Cash Flow | $245.22B | $120.67B |
| Operating Cash Flow | $3.92B | $3.36B |
| Cash & Equivalents | $5.33B | $7.56B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.